Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proton pump inhibitor comparison during dual antiplatelet therapy in acute coronary syndrome after PCI
ChiCTR-TRC-12002607Phase 4Completed
- Sponsor
- Jiangyin People's Hospital
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of omeprazole, lansoprazole, rabeprazole and esomeprazole in acute coronary syndrome (ACS) (4 arms), sponsored by Jiangyin People's Hospital. Primary endpoint: Clopidogrel platelet inhibition. Started Sep 2014; status: completed.
02
Drugs
omeprazolelansoprazolerabeprazoleesomeprazole
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on ChiCTR-TRC-12002607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002607.